| 1 |
33875422 | Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment. | 2021 Jun 17 |
1 |
| 2 |
32864162 | Pharmacogenomics of COVID-19 therapies. | 2020 |
1 |
| 3 |
29174535 | Prediction of inter-individual variability on the pharmacokinetics of CYP2C8 substrates in human. | 2017 Dec |
1 |
| 4 |
27467145 | Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses. | 2016 |
3 |
| 5 |
22531455 | Distribution of human CYP2C8*2 allele in three different African populations. | 2012 Apr 25 |
2 |
| 6 |
21998472 | Human genetic variation is associated with Plasmodium falciparum drug resistance. | 2011 Dec 1 |
1 |
| 7 |
19560616 | [Chloroquine cardiotoxicity in long-term lupus therapy in two patients]. | 2009 Jun-Jul |
1 |
| 8 |
17286541 | CYP2C8 and antimalaria drug efficacy. | 2007 Feb |
1 |
| 9 |
12756207 | In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. | 2003 Jun |
2 |
| 10 |
12967198 | Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes. | 2003 Aug |
2 |